Globitair

Gannet BioChem and Re-Vana Therapeutics Enter Development and cGMP Supply Agreement to Support Ophthalmic Drug Delivery Program

Financial PostUnited States of America

The agreement supports EyeLief® combination drug-device product development in anticipation of a future clinical program, with polymer supply also supporting OcuLief® and non-ocular applications HUNTSVILLE, Ala., Oct. 27, 2026 (GLOBE NEWSWIRE) — Gannet BioChem, a specialized contract development and manufacturing organization (CDMO) focused on activated polymers and bioconjugation, and Re-Vana Therapeutics, a biotechnology company developing […]

Read the full story at Financial PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America